Article

<i>TP53</i> mutations promote immunogenic activity in breast cancer

2018-06-24

Abstract excerpt

<h4>Background</h4> Although immunotherapy has recently achieved clinical successes in a variety of cancers, thus far there is no any immunotherapeutic strategy for breast cancer (BC). Thus, it is important to discover biomarkers for identifying the BC patients responsive to immunotherapy. TP53 mutations were often associated with worse clinical outcome in BC, of which the triple-negative BC (TNBC) has a high T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 683e7c85-37fa-551c-99ac-38d510ac234f
DOI: 10.1101/354779

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

<i>TP53</i> mutations promote immunogenic activity in breast cancerDOI 10.1101/354779Read

A Comprehensive Immunologic Portrait of Triple-Negative Breast CancerSemantic proximity Read

TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast CancerSemantic proximity Read

Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell TranscriptomesSemantic proximity Read

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity Read

Novel Immune Subtypes Identification of HER2 Positive Breast Cancer Based On Immunogenomic LandscapeSemantic proximity Read

A scoring screening system based on machine learning for immunotherapy beneficiaries in triple-negative breast cancerSemantic proximity Read

Interleukin-17-based cytokine signaling as a determinant for tumor immune microenvironment with prognostic value in triple-negative breast cancerSemantic proximity Read

The Negative Correlation Between TNBC Mutation Frequency and Immune Function: Is Immune Involvement in Regulating Mutations?Semantic proximity Read

Immune Microenvironment-Related Genes Contribute to Clinical Prognosis in Patients with Triple-Negative Breast CancerSemantic proximity Read

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast CancerSemantic proximity Read

TP53 signature score predicts prognosis and immune response in triple-negative breast cancerSemantic proximity Read

Immune-related Gene Data-based Molecular Subtyping Related to the Prognosis for Breast Cancer PatientsSemantic proximity Read